Utility of IOLMaster 700 Swept-Source Optical Coherence Tomography in Detecting Macular Disease for Preoperative Cataract Surgery Patients

Purpose To assess the efficacy of IOLMaster 700 (IOLM) biometer swept-source optical coherence tomography (SS-OCT) in detecting macular pathology before cataract surgery and to compare IOLM SS-OCT characteristics of foveal pathology with a widely used spectral-domain OCT (SD-OCT) system. Patients and Methods Retrospective analysis of 1156 consecutive eyes with IOLMaster 700 SS-OCT undergoing cataract surgery from January to June 2017 was performed. Approximately a third of these eyes (327 eyes) also had a SD-OCT scan performed previously. A single reviewer assessed each SS-OCT scan and identified them as “normal” or “abnormal.” SS-OCT sensitivity and specificity in identifying foveal pathology was assessed using findings on Spectralis SD-OCT scans as the gold standard. Results Of 327 eyes with both IOLM SS-OCT and Spectralis SD-OCT scans, 121 eyes (37.0%) had abnormal SS-OCT scans. Of these 121 eyes, SD-OCT scans confirmed pathology in 104 eyes (86.0%). Of the remaining 206 eyes graded to have normal SS-OCT scans, 84 eyes (40.8%) had normal SD-OCT scans, and 122 eyes (59.2%) had pathologic findings on SD-OCT scans. For each pathologic condition, subtle but definitive differences existed in the appearance of the IOLM SS-OCT and SD-OCT images. Conclusion Using a normal or abnormal Spectralis SD-OCT scan as confirmation of absence or presence of foveal pathology respectively, we found a high positive predictive value (86.0%) of an abnormal IOLM SS-OCT scan and a high specificity (83.2%) but low sensitivity (46.0%) and negative predictive value (40.8%) of a normal-appearing SS-OCT scan. These results suggest that an abnormal IOLM SS-OCT scan in an eye without known pathology is a strong indicator of an abnormal macula and should prompt further evaluation of the retina to identify pathology prior to cataract surgery. Importantly, IOLM SS-OCT scans do not detect all macular pathology and cannot be used as a screening test for identifying macular pathology.

[1]  D. Tognetto,et al.  Swept-Source Optical Coherence Tomography Biometer as Screening Strategy for Macular Disease in Patients Scheduled for Cataract Surgery , 2019, Scientific Reports.

[2]  E. Gabison,et al.  Preoperative spectral-domain optical coherence tomography in patients having cataract surgery. , 2018, Journal of cataract and refractive surgery.

[3]  Andrew Catran,et al.  Yield of routine pre‐cataract surgery macular optical coherence tomography in finding clinically undetected macular pathology , 2017, Clinical & experimental ophthalmology.

[4]  Jess J. Behrens,et al.  Rates of Routine Cataract Surgery Among Medicare Beneficiaries , 2017, JAMA ophthalmology.

[5]  O. Findl,et al.  Macular disease detection with a swept‐source optical coherence tomography‐based biometry device in patients scheduled for cataract surgery , 2016, Journal of cataract and refractive surgery.

[6]  B. Klein,et al.  Preoperative macular spectral‐domain optical coherence tomography in patients considering advanced‐technology intraocular lenses for cataract surgery , 2016, Journal of cataract and refractive surgery.

[7]  SriniVas R Sadda,et al.  Comparison of macular choroidal thicknesses from swept source and spectral domain optical coherence tomography , 2015, British Journal of Ophthalmology.

[8]  Colin S. Tan,et al.  Comparison of choroidal thicknesses using swept source and spectral domain optical coherence tomography in diseased and normal eyes , 2014, British Journal of Ophthalmology.

[9]  Jay S Duker,et al.  Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes , 2013, British Journal of Ophthalmology.

[10]  Daini Ong,et al.  Should macular optical coherence tomography be part of routine preoperative cataract assessment? , 2012, Clinical & experimental ophthalmology.